A polyfluoro-substituted aromatic heterocyclic derivative having the structure as represented by formula I or formula I′, wherein at least one of R1 and R2 is a fluorine atom, and at least two substituents of Rc, Rd, Re, and Rf are fluorine atoms; and an optical isomer of the derivative, or a pharmaceutically acceptable salt or solvate of the same, or a pharmaceutically acceptable salt or solvate of the optical isomer of the same. A composition containing the polyfluoro-substituted aromatic heterocyclic derivative and an application of the composition in preparing an anti-tumour medicament. The compound provides significant inhibitory effects with respect to Akt1 and demonstrates strong proliferation inhibitory activity with respect to tumour cell lines such as an ovarian cancer cell line, a colon cancer cell line, and a prostate cancer cell line. Therefore, the compound may be used as an Akt inhibitor in the medicament for treating a cell proliferation-related solid tumour or blood cancer in the human or animal body.
一种具有式Ⅰ或式Ⅰ′所代表结构的多
氟取代芳香杂环衍
生物,其中R1和R2中至少有一个是
氟原子,Rc、Rd、Re和Rf中至少有两个取代基是
氟原子;以及该衍
生物的光学异构体,或其药学上可接受的盐或溶液,或其光学异构体的药学上可接受的盐或溶液。一种含有多
氟取代芳香杂环衍
生物的组合物,以及该组合物在制备
抗肿瘤药物中的应用。该化合物对 Akt1 具有明显的抑制作用,对卵巢癌
细胞系、结肠癌
细胞系和前列腺癌
细胞系等肿瘤
细胞系具有很强的增殖抑制活性。因此,该化合物可作为一种
Akt 抑制剂,用于治疗人或动物体内与细胞增殖相关的实体瘤或血癌的药物中。